Main > OPHTHALMOLOGY > CH. R. Wet AMD>Treat.>VEGF-A MAb>

---

CH. R. Wet AMD>Treat.>VEGF-A MAb>'s subsections
(*) USA Approval Date: 2021. 10.22
>Inj. Intravitreal Use>Via Ocular>
Company
Company Licensee USA
Generic Name: ranibizuMAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 12.21.
PR Web-Site
RTM

CH. R. Wet AMD>Treat.>VEGF-A MAb>'s products
This section has no products